Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Razia Khanam has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions

    by Faraha Ahmed, Pinki Mishra, Razia Khanam

    Background: Cellular senescence contributes to aging, chronic inflammation, and age-related diseases. Senolytics eliminate senescent cells, whereas senomorphics modulate their pathological activities, including the senescence-associated secretory phenotype (SASP). This review examines their mechanisms, preclinical and clinical evidence, safety, and translational challenges. Methods: Published mechanistic, preclinical, and clinical literature on senolytic and senomorphic therapies was reviewed, focusing on therapeutic targets, disease-specific findings, safety, and clinical translation. Results: Senolytics, including dasatinib plus quercetin, navitoclax, and fisetin, target senescent-cell survival pathways, whereas senomorphics, including rapamycin, metformin, and Janus kinase inhibitors, modulate inflammatory signaling and SASP-associated pathways. Preclinical studies suggest benefits across metabolic, cardiovascular, musculoskeletal, and neurodegenerative disease models. However, human evidence remains limited and heterogeneous. Early clinical studies demonstrate the feasibility of senescence targeting and changes in selected biomarkers, but consistent clinical benefit remains unestablished. Major challenges include senescent-cell heterogeneity, insufficiently validated biomarkers, treatment-related toxicity, and the physiological roles of senescence in tissue repair and tumor suppression. Conclusions: Senolytics and senomorphics are promising but investigational therapeutic strategies. Clinical translation requires validated biomarkers, disease-specific patient selection, improved therapeutic selectivity, adequately powered trials with clinically meaningful endpoints, and long-term safety assessment. Aligning therapeutic strategies with senescent-cell phenotypes, disease context, and treatment objectives may improve clinical relevance.

  • Open Access

    Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges

    by Shery Jacob, Namitha Raichel Varkey, Rekha Rao, Pottathil Shinu, Razia Khanam

    Biomimetic cell membrane-coated nanoparticles (CM-NPs) have emerged as a promising class of nanocarriers that integrate the tunable physicochemical properties of engineered nanoparticles with selected biological features of naturally derived cell membranes. By retaining membrane-associated proteins, lipids, glycans, and receptors, CM-NPs have demonstrated the potential to modulate immune recognition, prolong systemic circulation, improve biocompatibility, and facilitate disease-specific targeting; however, these effects depend on the membrane source, nanoparticle composition, coating integrity, fabrication method, and biological context. This review critically examines major membrane-engineering strategies, including lipid insertion, covalent conjugation, metabolic glycoengineering, and genetic modification, together with fabrication methods such as extrusion, sonication, electroporation, in situ polymerization, and microfluidics. Particular emphasis is placed on nanoparticles coated with erythrocyte, platelet, stem cell, immune cell, bacterial, cancer cell, and hybrid membranes. Their therapeutic applications are critically evaluated, with a primary focus on cancer therapy, including photothermal and photodynamic approaches, alongside applications in cardiovascular, neurological, infectious, inflammatory, and regenerative diseases. Recent CM-NP platforms are systematically summarized according to membrane source, therapeutic cargo or nanoparticle core, disease application, and major outcomes, while recent patents are discussed to highlight emerging technological and translational developments. Despite encouraging preclinical findings, clinical translation remains constrained by challenges in membrane isolation and purification, batch reproducibility, manufacturing scalability, preservation of membrane integrity and functionality, quality control, long-term stability, biosafety, and regulatory standardization. Advances in membrane engineering, hybrid membrane systems, scalable manufacturing, standardized characterization, and rigorous safety evaluation will be important for advancing CM-NPs toward clinical translation.

  • Bringing Senotherapeutics from Research to Patient Care

    by Razia Khanam

    The evolution of senotherapeutics began with first-generation senolytics targeting antiapoptotic pathways in senescent cells. More recent strategies involve marker-specific targeting, addressing the limitations of current therapies and aiming for greater precision. This has led to the development of second-generation senotherapeutics, including senoblockers (prevent senescence) and senoreversers (reverse established senescence). While still in the early to middle stages, future success depends on long-term efficacy, safety validation, and advancements in biomarker discovery, senescence heterogeneity, and precision drug design. Key developments include biomarker identification for detecting in vivo senescence, targeted therapy development with minimal toxicity, multidisciplinary integration of genetics, metabolomics, and artificial intelligence, single-cell technology to understand senescence dynamics and greater investment and global collaboration. These therapies represent a shift from disease-focused care to aging-centered, preventive medicine, with the potential to transform healthcare and usher in a new era of regenerative, longevity science.

  • Senotherapeutics

    by Razia Khanam, Divya Vohora

    This book provides a comprehensive overview of the emerging field of senotherapeutics and its potential applications in various diseases. The initial chapter

  • Senotherapeutics in Neurological Disorders

    by Faraha Ahmed, Razia Khanam

    Neurological disorders primarily are an outcome of neurodegeneration, which is an age-associated progressive decline in neuronal activity. It causes cognitive dysfunction characterized by apoptosis and DNA damage. A considerable aging hallmark is cellular senescence that involves epigenetic, genetic and environmental factors. The proliferative cessation of the cell cycle is irreversible and is a well-regulated process that has favourable as well as deleterious effects in the body. Cellular senescence helps in removal of damaged proteins from the cells and decreases autophagic flux. There is substantial telomere shortening, mitochondrial dysfunction and inflammation. Senescent cells upregulate SCAP (senescent cell anti-apoptotic pathway) and display distinct SASP (senescence-associated secretory phenotype) that hinder their death regardless of damage to cell organelles and DNA. Aging hallmarks, specifically senescence, are crucial for neurological disorders including Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, epilepsy and amyotrophic lateral sclerosis. Therefore, targeting senescence therapeutically may offer improved and extended lifespan. The therapeutic targets include SASP and SCAP that led to the advancement in senotherapeutic agents that cause senescent cell death selectively. The drugs that target the arrest of specific senescent cells are recognised as senolytics, while the drugs that target SASP are known as senomorphics. Here we discuss the mechanism of cellular senescence in several neurological disorders in addition to the advancements in senotherapeutics that help to ameliorate neurological insufficiency.

  • Open Access

    Bidirectional Relationship between COVID-19 and Diabetes

    by Razia Khanam

    Numerous reports have suggested that diabetic patients are at high risk for the development of severe symptoms of coronavirus disease-2019 (COVID-19). However, a few studies have recently proposed that the relationship between diabetes and COVID-19 is bidirectional, as severe acute respiratory syndrome-coronavirus-2 also has the capability to induce diabetes. Various mechanisms have been identified and proposed to be involved in this binary association. In this review, the importance and impact of renin–angiotensin–aldosterone system (RAAS) in this two-way association of COVID-19 and diabetes has been summarized. The role and effect of drugs modulating RAAS directly or indirectly has also been discussed, as they can majorly impact the course of treatment in such patients. Further reports and data can present a clear picture of RAAS and its modulators in restoring the balance of dysregulated RAAS in COVID-19.


  • Heavy metals in hair and nails as markers of occupational hazard among welders working in United Arab Emirates

    by Hisaa Nassir Abdulla Lotah, Anoop Kumar Agarwal, Razia Khanam

    Studies have shown that hair and nail samples can be used as a marker to assess occupational exposure to heavy metals. The objective of this study was to estimate the levels of heavy metals: Lead (Pb), Nickel (Ni), Cadmium (Cd), and Manganese (Mn) in hair and nail samples of welders working in United Arab Emirates and to find an association between the heavy metal concentration with the parameters like smoking habits, exposure/day, years of experience and use of protective personal equipment (PPE). Hair and toes nail samples were collected from exposed and non-exposed subjects with respect to, social habits, exposure/day and years of welding experience. The levels of Pb, Cd, Mn, and Ni, in hair and toenails, assayed by atomic absorption spectrophotometer. We observed that the metal concentration was higher in toenail as compared to hair samples in both the groups. Cd was significantly high in both the groups whereas, Mn in the hair was high in the exposed group. The Mn in hair was notably higher among smokers and the Cd in hair and Ni in the nail samples was significantly higher in the subjects with > 8 h/day exposure. The concentration of Cd and Ni in hair increased with increasing years of experience and was maximum in the subjects with welding experience of > 20 years. Our results signify that hair and nail samples can be used as an indicator to heavy metal exposure. Given that the present study shows high level of some metals in the hair and nail of welders, awareness of occupational hazards and annual assessment of welder’s health is necessary.


  • Analysis of phthalate esters in two different baby care products available in United Arab Emirates

    by Saba Farooqi, K. Rajendran, Razia Khanam

    Phthalates are used as plasticizers in a wide range of products and are known to affect the human health adversely. Hence, the present study was carried out to identify and quantify the presence of four phthalates namely dimethyl phthalate (DMP), dibutyl phthalate (DBP), and diethyl phthalate (DEP), di (2-ethylhexyl) phthalate (DEHP) in the two baby products i.e. baby oils and baby lotions. The daily exposure levels and hazard index of each phthalate were also calculated. It was an analytical study where two different brands of samples of baby oil and baby lotion each, from the date of manufacturing of 3, 10, and 20 months were collected. The extraction of phthalates from different samples was done and analyzed using HPTLC. Results showed the presence of all four phthalates, although some phthalates were not present in 3 M samples. The maximum concentration of all the phthalates was found in 20 M samples. Their concentration increased with the storage time indicating the possibility of leaching and migration of phthalates from the container into the product. The hazard indices for phthalates estimated for baby oil and baby lotion were found below 1, which denotes that the daily phthalate exposures are within the regulatory limits. It is important to consider that the exposure to phthalates can occur not only by dermal contact of these baby products but also through other routes. Hence, the study signifies the importance of phthalates concentration in such regularly used products.